A research team from the Zhejiang Provincial Bureau of Statistics paid a visit to JibaiChuan, focusing on the operation of eco‑industries.
Release date:
2025-10-24
On the morning of October 24, 2025, a research delegation from the Zhejiang Provincial Bureau of Statistics paid a visit to JibaiChuan Pharmaceutical to conduct an inspection and assessment of the company’s production and operations as well as the development of its industry. The delegation included Wu Jiaxi, Deputy Secretary of the Party Leadership Group, Deputy Director, and First‑Level Inspector of the Provincial Bureau of Statistics; Xu Haibiao, Second‑Level Inspector of the Industrial Statistics Division; Xu Mingjuan, Director of the Social and Science & Technology Statistics Division; Wang Chen, First‑Level Chief Staff Member of the Industrial Statistics Division; and other officials. Xiang Shiyang, Party Secretary and Director of the Jinhua Municipal Bureau of Statistics, along with other accompanying officials, also participated in the visit.

The research team conducted an on-site inspection of the JibaiChuan Oriental Ganoderma Culture Museum and the production workshop, gaining an in-depth understanding of the company’s end-to-end industrial chain in the ganoderma sector, from cultivation to sales. During the visit, the team placed particular emphasis on the company’s pioneering… “Wilding cultivation under the yew forest” This approach establishes a natural, wild‑adapted growing environment beneath the yew forest, ensuring the authentic, high‑quality nature of Ganoderma while fostering a “forest–medicinal plant symbiosis” ecosystem that effectively safeguards forest resources.

Bao Jiajin, Chairman of JibaiChuan, provided the research team with a detailed briefing on the company’s current operational and production status, as well as its achievements and plans in areas such as technological integration and innovation. He stated that JibaiChuan has articulated a development strategy centered on the synergistic integration of ecological and economic benefits, thereby underscoring the company’s unwavering confidence in steady growth and its pragmatic approach.

In the future, the company will continue to uphold “Seek health from the forest, and a future from ecology.” Its development philosophy emphasizes ecological conservation while continuously refining its production and business strategies, driving the ganoderma industry toward higher standards and greater value.
Related Recommendations